Left ventricular assist devices and bleeding: Adding insult to injury

Annals of Thoracic Surgery

Volumn 75, Issue 6 SUPPL., 2003, Pages

  Goldstein, Daniel J ^a   Beauford, Robert B ^a  

^a NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CONFERENCE PAPER; ENDOCARDIAL HEMORRHAGE; FATALITY; HEART ASSIST DEVICE; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMOSTASIS; HUMAN; IMPLANTATION; INFECTION; INTRAOPERATIVE PERIOD; LUNG INSUFFICIENCY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; SECOND LOOK SURGERY; VIRUS TRANSMISSION;

HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; POSTOPERATIVE HEMORRHAGE;

EID: 0037636659     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00478-8     Document Type: Conference Paper

References (31)

1. Pavie A, Szefner J, Leger P, Gandjbakhch I. Preventing, minimizing, and managing postoperative bleeding. Ann Thorac Surg 1999;68:705-10.
2. Schmid C, Scheld HH, Hammel D. Control of perigraft bleeding during ventricular assist device implantation. Ann Thorac Surg 2000;69:958-9.
3. Zietkiewicz M, Garlicki M, Domagala J, et al. Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device. J Thorac Cardiovasc Surg 2002;123:384-5.
4. Van Meter CH. Perioperative management of bleeding. In: Goldstein DJ, Oz MC, eds. Cardiac assist devices. New York: Futura Publishing Co, 2000:75-82.
5. Spiess BD. Blood transfusion: the silent epidemic. Ann Thorac Surg 2001;72(Suppl):1832-7.
6. Murphy PJ, Connery C, Hicks GL Jr, Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1992;104:1092-9.
7. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968-71.
8. Goldstein DJ, Seldomridge JA, Chen JM, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg 1995;59:1063-8.
9. Chen JM, Rose EA. Management of perioperative right-sided circulatory failure. In: Cardiac assist devices. Goldstein DJ, Oz MC, eds. New York: Futura Publishing Co, 2000:83-102.
10. Heptinstall S, Groenewegen WA, Spangenberg P, Loesche W. Extracts of feverfew may inhibit platelet behavior via neutralization of sulphhydryl groups. J Pharm Pharmacol 1987;39:459-65.
11. Makheja AN, Bailey J. The active principle in feverfew [letter]. Lancet 1981;2:1054.
12. Cooperative Group for Essential Oil of Garlic. The effect of essential oil of garlic on hyperlipidemia and platelet aggregation: an analysis of 308 cases. J Tradit Chin Med 1986;6:117-20.
13. Backon J. Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry. Med Hypothesis 1986;20:271-8.
14. Chung KF, McCusker M, Page CP, Dent G, Guinoit P, Barnes PJ. Effect of gingkolide mixture in antagonizing skin and platelet responsiveness to platelet activating factor in man. Lancet 1987;1:248-51.
15. Kuo SC, Teng CM, Lee JG, Ko FN, Chen SC, Wu TS. Antiplatelet components in Panax ginseng. Planta Med 1990;56:164-7.
16. Cheema P, El-Mefty O, Jazieh AR. Intraoperative hemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of the literature. J Intern Med 2001;250:167-9.
17. Kaplon RJ, Gillinov AM, Smedira NG, et al. Vitamin K reduces bleeding in left ventricular assist device recipients. J Heart Lung Transplant 1999;18:346-50.
18. Blee TH, Cogbill TH, Lambert PJ. Hemorrhage associated with vitamin C deficiency in surgical patients. Surgery 2002;131:408-12.
19. Buo L, Karlsrud TS, Dyrhaug G, et al. The fibrinolytic system in human ascites. Scand J Gastroenterol 1995;30:1101-7.
20. Wilde JT, Cooper P, Kennedy HJ, Triger DR, Preston FE. Coagulation disturbances following ascites recirculation. J Hepatol 1990;10:217-22.
21. Goldstein DJ, Oz MC, Smith CR, et al. Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation. Ann Thorac Surg 1996;61:692-5.
22. Mochizuli T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 1998;8:781-5.
23. Despotis GJ, Joist J, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of point of care testing on blood loss and transfusion outcomes. Clin Chem 1997;43:1684-96.
24. Faraday N, Guallar E, Sera VA, et al. Utility of whole blood hemostatometry using the clot signature anaslyzer for assessment of hemostasis in cardiac surgery. Anesthesiol 2002;96:1115-22.
25. Zietkiewica M, Garlicki M, Domagala J, et al. Successful use of activated recombinant factor VV to control bleeding abnormalities in a patient with a left ventricular assist device. J Thorac Cardiovasc Surg 2002;123:384-5.
26. Al Douri M, Shafi T, Al Khudairi D, et al. Effect of the administration of recombinant activated factor VII in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinol 2000;11(Suppl 1):S121-7.
27. Sano H, Koga Y, Hamasaki K, Furuyama H, Itami N. Anaphylaxis associated with white-cell reduction filter. Lancet 1996;347:1053.
28. Slater JP, Rose EA, Levin HR, Frazier OH, Roberts JK, Oz MC. Low thromboembolic risk without anticoagulation using advanced design left ventricular assist devices. Ann Thorac Surg 1996;62:1321-7.
29. Rose EA, Levin HR, Oz MC, et al. Artificial circulatory support with texture interior surfaces: a counterintuitive approach to minimize thromboembolism. Circulation 1994;90:II87-91.
30. Livingston ER, Fisher CA, Bibidakis EJ, et al. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation 1996;94:II227-34.
31. Spanier T, Oz M, Levin H, Weinberg A, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 1996;112:1090-7.